Millennium Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-344,320
| Closed | -$13.5M | – | 4248 |
|
|
2025
Q1 | $13.5M | Buy |
+344,320
| New | +$13.5M | 0.01% | 1318 |
|
|
2024
Q4 | – | Sell |
-51,267
| Closed | -$2.58M | – | 4298 |
|
|
2024
Q3 | $2.58M | Sell |
51,267
-165,697
| -76% | -$8.35M | ﹤0.01% | 2400 |
|
|
2024
Q2 | $9.54M | Buy |
216,964
+195,989
| +934% | +$8.62M | ﹤0.01% | 1488 |
|
|
2024
Q1 | $1.05M | Sell |
20,975
-53,133
| -72% | -$2.67M | ﹤0.01% | 2932 |
|
|
2023
Q4 | $4.48M | Buy |
74,108
+43,578
| +143% | +$2.63M | ﹤0.01% | 1968 |
|
|
2023
Q3 | $1.74M | Sell |
30,530
-161,874
| -84% | -$9.23M | ﹤0.01% | 2575 |
|
|
2023
Q2 | $9.81M | Buy |
192,404
+157,333
| +449% | +$8.02M | ﹤0.01% | 1481 |
|
|
2023
Q1 | $750K | Buy |
+35,071
| New | +$750K | ﹤0.01% | 3220 |
|
|
2022
Q3 | – | Sell |
-28,090
| Closed | -$147K | – | 5379 |
|
|
2022
Q2 | $147K | Sell |
28,090
-120,135
| -81% | -$629K | ﹤0.01% | 4578 |
|
|
2022
Q1 | $1.65M | Buy |
148,225
+92,490
| +166% | +$1.03M | ﹤0.01% | 3205 |
|
|
2021
Q4 | $551K | Hold |
55,735
| – | – | ﹤0.01% | 3932 |
|
|
2021
Q3 | $555K | Hold |
55,735
| – | – | ﹤0.01% | 4099 |
|
|
2021
Q2 | $577K | Buy |
55,735
+35,735
| +179% | +$370K | ﹤0.01% | 4091 |
|
|
2021
Q1 | $204K | Hold |
20,000
| – | – | ﹤0.01% | 4147 |
|
|
2020
Q4 | $227K | Buy |
+20,000
| New | +$227K | ﹤0.01% | 3666 |
|